The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
Open accessAbstract
Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, suggesting that understanding the mechanism of kinase activation and regulation may be important for the development of specific kinase inhibitors for Parkinson disease treatment. Here, we show that LRRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions. Furthermore, an intact C terminus, but not N terminus, is required for autophosphorylation activity. We identify two residues in the activation loop that contribute to the regulation of LRRK2 autophosphorylation. Finally, we demonstrate that LRRK2 undergoes intramolecular autophosphorylation. Together, these results provide insight into the mechanism and regulation of LRRK2 kinase activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.4876 · Cited by 38,993
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Self-citationParkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Nolen, B., Taylor, S., & Ghosh, G. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.024 · Cited by 1,167
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
Self-citationA new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., & Obata, F. (2002) · Annals of Neurology · doi:10.1002/ana.10113 · Cited by 667
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Ohren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb859 · Cited by 626
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.-L., Dawson, V. L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl471 · Cited by 533
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., & Ueffing, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi439 · Cited by 477
Jaleel, M., Nichols, R. J., Deak, M., Campbell, D. G., Gillardon, F., Knebel, A., & Alessi, D. R. (2007) · Biochemical Journal · doi:10.1042/bj20070209 · Cited by 472
Xiang, Z., Soto, C. S., & Honig, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102179699 · Cited by 367
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A., & Cookson, M. R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.006 · Cited by 273
Self-citationAn LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., & Iwatsubo, T. (2007) · Biochemistry · doi:10.1021/bi061960m · Cited by 263
Deng, J., Lewis, P. A., Greggio, E., Sluch, E., Beilina, A., & Cookson, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709098105 · Cited by 245
Self-citationLi, X., Tan, Y., Poulose, S., Olanow, C. W., Huang, X., & Yue, Z. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04743.x · Cited by 230
Guo, L., Gandhi, P. N., Wang, W., Petersen, R. B., Wilson-Delfosse, A. L., & Chen, S. G. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.007 · Cited by 208
Luzon-Toro, B., de la Torre, E. R., Delgado, A., Perez-Tur, J., & Hilfiker, S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm151 · Cited by 122
LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain
Korr, D., Toschi, L., Donner, P., Pohlenz, H., Kreft, B., & Weiss, B. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.015 · Cited by 115
Melrose, H. L., Kent, C., Taylor, J. P., Dächsel, J. C., Hinkle, K. M., Lincoln, S. J., Mok, S. S., Culvenor, J. G., Masters, C. L., Tyndall, G., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.027 · Cited by 109
Direct binding of α‐actinin enhances TRPP3 channel activity
Li, Q., Dai, X., Shen, P. Y., Wu, Y., Long, W., Chen, C. X., Hussain, Z., Wang, S., & Chen, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04940.x · Cited by 105
G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
Brás, J., Guerreiro, R. J., Ribeiro, M. H., Januário, C., Morgadinho, A., Oliveira, C. R., Cunha, L., Hardy, J., & Singleton, A. (2005) · Movement Disorders · doi:10.1002/mds.20682 · Cited by 99
Greggio, E., Lewis, P. A., van der Brug, M. P., Ahmad, R., Kaganovich, A., Ding, J., Beilina, A. G., Baker, A. K., & Cookson, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04523.x · Cited by 90
Self-citationRole of the ASK1-SEK1-JNK1-HIPK1 Signal in Daxx Trafficking and ASK1 Oligomerization
Song, J. J., & Lee, Y. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213201200 · Cited by 88
Leung, I. W.-L., & Lassam, N. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004092200 · Cited by 86
Identification of potential protein interactors of Lrrk2
Dächsel, J. C., Taylor, J. P., Mok, S. S., Ross, O. A., Hinkle, K. M., Bailey, R. M., Hines, J. H., Szutu, J., Madden, B. J., Petrucelli, L., et al. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.01.008 · Cited by 84
Bonifati, V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9324-y · Cited by 82
Networks for the allosteric control of protein kinases
Shi, Z., Resing, K. A., & Ahn, N. G. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.10.011 · Cited by 78
SPARKS 2 and SP3 servers in CASP6
Zhou, H., & Zhou, Y. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20732 · Cited by 73
Dimerization through the Catalytic Domain Is Essential for MEKK2 Activation
Cheng, J., Yu, L., Zhang, D., Huang, Q., Spencer, D. M., & Su, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414258200 · Cited by 49
Clinical and pathologic features of families with LRRK2-associated Parkinson’s disease
Whaley, N. R., Uitti, R. J., Dickson, D. W., Farrer, M. J., & Wszołek, Z. K. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_34 · Cited by 30
Cited by
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Interplay of LRRK2 with chaperone-mediated autophagy
Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L. S., Dauer, W., Consiglio, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3350 · Cited by 588
Nuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Self-citation
Metadata
- Authors
- Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.-M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A., Thomas, K. J., Baekelandt, V., & Cookson, M. R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 283
- Issue
- 24
- Pages
- 16906-16914
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2032206743
- Cited by
- 308
- References
- 35
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.